Partially Mismatched Transplantation and Human Leukocyte Antigen Donor-Specific Antibodies

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 4, 2013, Pages 647-652

  Gladstone, Douglas E ^a   Zachary, Andrea A ^a   Fuchs, Ephraim J ^a   Luznik, Leo ^a   Kasamon, Yvette L ^a   King, Karen E ^b   Brodsky, Robert A ^a   Jones, Richard J ^a   Leffell, Mary S ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Desensitization; Donor specific antibodies; Haploidentical allogeneic bone marrow transplantation

Indexed keywords

HLA ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD DONOR; BLOOD GROUP TYPING; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DESENSITIZATION; FEMALE; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; IMMUNOASSAY; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; UNRELATED DONORS;

ADULT; AGED; BONE MARROW TRANSPLANTATION; CHILD; DESENSITIZATION, IMMUNOLOGIC; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84875503612     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.01.016     Document Type: Article

References (29)

1. Thomas' Hematopoietic Cell Transplantation 2004, Blackwell, Malden, Mass. 3rd ed. K.G. Blume (Ed.).
2. Grewal S.S., Barker J.N., Davies S.M., Wagner J.E. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood 2003, 101:4233-4244.
3. Dew A., Collins D., Artz A., et al. Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options. Biol Blood Marrow Transplant 2008, 14:938-941.
4. Luznik L., Jalla S., Engstrom L.W., et al. Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. Blood 2001, 98:3456-3464.
5. Luznik L., O'Donnell P.V., Symons H.J., et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008, 14:641-650.
6. Kasamon Y.L., Luznik L., Leffell M.S., et al. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant 2010, 16:482-489.
7. Brunstein C.G., Fuchs E.J., Carter S.L., et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011, 118:282-288.
8. National Marrow Donor Program, Health Resources and Services Administration, Healthcare Systems Bureau. Donor Registry Transplant Data. Last Updated: February 5, 2011. http://bloodcell.transplant.hrsa.gov/RESEARCH/Transplant_Data/Registry_Tx_Data/index.html.
9. Zachary A.A., Leffell M.S. Barriers to successful transplantation of the sensitized patient. Expert Rev Clin Immunol 2010, 6:449-460.
10. Anasetti C., Amos D., Beatty P.G., et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989, 320:197-204.
11. Taylor P.A., Ehrhardt M.J., Roforth M.M., et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood 2007, 109:1307-1315.
12. Ciurea S.O., de Lima M., Cano P., et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 2009, 88:1019-1024.
13. Ciurea S.O., Thall P.F., Wang X., et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood 2011, 118:5957-5964.
14. Cutler C., Kim H.T., Sun L., et al. Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood 2011, 118:6691-6697.
15. Spellman S., Bray R., Rosen-Bronson S., et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 2010, 115:2704-2708.
16. Takanashi M., Atsuta Y., Fujiwara K., et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood 2010, 116:2839-2846.
17. Zachary A.A., Sholander J.T., Houp J.A., Leffell M.S. Using real data for a virtual crossmatch. Hum Immunol 2009, 70:574-579.
18. Zachary A.A., Lucas D.P., Detrick B., Leffell M.S. Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol 2009, 70:496-501.
19. Zachary A.A., Leffell M.S. Detecting and monitoring human leukocyte antigen-specific antibodies. Hum Immunol 2008, 69:591-604.
20. Leffell M.S. The calculated panel reactive antibody policy: an advancement improving organ allocation. Curr Opin Organ Transplant 2011, 16:404-409.
21. Montgomery R.A., Lonze B.E., King K.E., et al. Desensitization in HLA-incompatible kidney recipients and survival. New Engl J Med 2011, 365:318-326.
22. Montgomery R.A., Zachary A.A. Transplanting patients with a positive donor-specific crossmatch: a single center's perspective. Pediatr Transplant 2004, 8:535-542.
23. Montgomery R.A., Zachary A.A., Racusen L.C., et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000, 70:887-895.
24. Focosi D., Zucca A., Scatena F. The role of anti-HLA antibodies in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011, 17:1585-1588.
25. Gebel H.M., Bray R.A. Sensitization and sensitivity: defining the unsensitized patient. Transplantation 2000, 69:1370-1374.
26. Zachary A.A., Montgomery R.A., Leffell M.S. Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. Hum Immunol 2005, 66:364-370.
27. Zachary A.A., Montgomery R.A., Ratner L.E., et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 2003, 76:1519-1525.
28. Yoshihara S., Maruya E., Taniguchi K., et al. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transplant 2012, 47:508-515.
29. Brodsky R.A., Fuller A.K., Ratner L.E., et al. Elimination of alloantibodies by immunoablative high-dose cyclophosphamide. Transplantation 2001, 71:482-484.